To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Tumour-associated endothelial cells (TECs) are heterogeneous and plastic regulators of the tumour microenvironment. Their angiogenic, metabolic, barrier, and immunoregulatory programs influence tumour perfusion, metastatic dissemination, immune-cell access, and therapeutic response. However, the causal roles and clinical utility of many newly identified endothelial states remain uncertain.
Methods
This review examines the origins and functional heterogeneity of TECs, drawing on findings from single-cell and spatial studies. It discusses the implications of endothelial states for anti-angiogenic therapy, vascular normalization, immune modulation, drug delivery, combination treatment, and therapeutic resistance.
Results
Current evidence reveals endothelial states with distinct functional and therapeutic properties, although most remain descriptively characterized and lack causal or clinical validation. We propose a translational framework integrating single-cell and spatial profiling with protein-level validation, functional perturbation, vascular imaging, and longitudinal biomarkers to distinguish endothelial states that warrant suppression, normalization, reprogramming, or selective targeting.
Conclusions
TEC heterogeneity provides a rationale for precision vascular targeting. Establishing the causal functions and therapeutic relevance of endothelial states will be essential to advance vascular therapy beyond empirical angiogenesis inhibition and guide more selective treatment strategies.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.